ANDREW MATHIS: Open Payments
NPI 1801265004 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 17 payments from 11 companies in 2025. Trend: 2023 $194 · 2024 $233 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $158 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Exact Sciences Corporation | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
Products named: Ozempic, INGREZZA, CAPLYTA, Cologuard Collection Kit, Rybelsus, VOQUEZNA, BREZTRI, MOUNJARO.
Industry payments across IN — which companies pay providers there.
